$KROS Keros Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Keros Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Keros Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Keros Therapeutics, Inc. for free.
CIK Number: 0001664710
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: KROS
Company Address: 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON 02421
Phone number: 617-513-8774
Keros Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 2,650 | 795 | 129,705 | |
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 52.13 | 219 | 11,416 | 77,907 | 78.1 K to 77.9 K (-0.28 %) |
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 51.73 | 898 | 46,454 | 78,126 | 79 K to 78.1 K (-1.14 %) |
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 50.37 | 1,533 | 77,217 | 79,024 | 80.6 K to 79 K (-1.90 %) |
Jun 15 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 2,650 | 795 | 80,557 | 77.9 K to 80.6 K (+3.40 %) |
Jun 15 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Option Exercise | M | 0.48 | 1,000 | 480 | 98,211 | |
Jun 15 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Sell | S | 51.95 | 347 | 18,027 | 0 | 347 to 0 (-100.00 %) |
Jun 15 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Sell | S | 50.48 | 653 | 32,963 | 347 | 1,000 to 347 (-65.30 %) |
Jun 15 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Buy | M | 0.48 | 1,000 | 480 | 1,000 | 0 to 1,000 |
Jun 03 2021 | KROS | Keros Therapeutics ... | Farzan Nima | Director | Option Exercise | A | 51.48 | 8,293 | 426,924 | 8,293 | |
May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Option Exercise | M | 0.48 | 1,000 | 480 | 99,211 | |
May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Option Exercise | M | 0.48 | 1,000 | 480 | 99,211 | |
May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Sell | S | 50.15 | 1,000 | 50,150 | 0 | 1,000 to 0 (-100.00 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Sell | S | 50.15 | 1,000 | 50,150 | 0 | 1,000 to 0 (-100.00 %) |
May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Buy | M | 0.48 | 1,000 | 480 | 1,000 | 0 to 1,000 |